Chinese scientist He Jiankui wants to end Alzheimer’s and thinks Silicon Valley is conducting a “Nazi eugenic experiment.” ...

The Scottish Medicines Consortium (SMC) has approved the use of exagamglogene autotemcel to treat people with the chronic blood disease.

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...

In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Catie Matthews suggested that marketers should embrace artificial intelligence in their own lives.

Hormone replacement therapy can be a way for women to prevent the inflammation that leads to disease. "There's some bone ...

For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...

The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a promising way to improve existing cancer therapies ...

Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...

Repeated exercise, or wasting, can change the way key genes work.

This report is based on a recent in-depth article by the BBC, which examined how modern genetics is transforming scientific understanding of autism and reigniting debates within the autistic community ...

Optogenetics has long been a powerful experimental tool, but a growing body of research suggests it may now be approaching a ...

Oh, they’re on an upward track. The organization looks night and day from even a year ago. Early indications are that Dubas ...